Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilda Florentin

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Expert Opinion on Emerging Drugs|October 31, 2014
Emerging drugs for hyperlipidaemia: an updateMatilda Florentin, Michael S Kostapanos, Anastazia Kei, et al.
European Journal of Preventive Cardiology|August 14, 2021
Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overviewIoannis Parthymos, Michael S Kostapanos, Dimitri P Mikhailidis, et al.
International Journal of Molecular Sciences|February 15, 2022
Bone Health in Patients with Dyslipidemias: An Underestimated AspectPanagiotis Anagnostis, Matilda Florentin, Sarantis Livadas, et al.
Current Vascular Pharmacology|February 26, 2010
Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?Panagiotis Anagnostis, Vasilios G Athyros, Fotini Adamidou, et al.
Expert Opinion on Drug Safety|November 6, 2008
Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortalityEvangelos N Liberopoulos, Matilda Florentin, Dimitri P Mikhailidis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 5, 2006
Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronismAsterios Karagiannis, Konstantinos Tziomalos, Anna Kakafika, et al.
Expert Opinion on Emerging Drugs|February 18, 2011
Emerging options in the treatment of dyslipidemias: a bright future?Matilda Florentin, Evangelos N Liberopoulos, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|September 8, 2010
Vitamin D and metabolic syndrome: is there a link?Matilda Florentin, Moses S Elisaf, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|October 12, 2018
Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including RegistriesMatilda Florentin, Michael S Kostapanos, Moses S Elisaf, et al.
Current Vascular Pharmacology|October 31, 2013
Hemostatic factors and the metabolic syndromeMichael S Kostapanos, Matilda Florentin, Moses S Elisaf, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Expert Opinion on Emerging Drugs|October 31, 2014
Emerging drugs for hyperlipidaemia: an updateMatilda Florentin, Michael S Kostapanos, Anastazia Kei, et al.
European Journal of Preventive Cardiology|August 14, 2021
Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overviewIoannis Parthymos, Michael S Kostapanos, Dimitri P Mikhailidis, et al.
International Journal of Molecular Sciences|February 15, 2022
Bone Health in Patients with Dyslipidemias: An Underestimated AspectPanagiotis Anagnostis, Matilda Florentin, Sarantis Livadas, et al.
Current Vascular Pharmacology|February 26, 2010
Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?Panagiotis Anagnostis, Vasilios G Athyros, Fotini Adamidou, et al.
Expert Opinion on Drug Safety|November 6, 2008
Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortalityEvangelos N Liberopoulos, Matilda Florentin, Dimitri P Mikhailidis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 5, 2006
Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronismAsterios Karagiannis, Konstantinos Tziomalos, Anna Kakafika, et al.
Expert Opinion on Emerging Drugs|February 18, 2011
Emerging options in the treatment of dyslipidemias: a bright future?Matilda Florentin, Evangelos N Liberopoulos, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|September 8, 2010
Vitamin D and metabolic syndrome: is there a link?Matilda Florentin, Moses S Elisaf, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|October 12, 2018
Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including RegistriesMatilda Florentin, Michael S Kostapanos, Moses S Elisaf, et al.
Current Vascular Pharmacology|October 31, 2013
Hemostatic factors and the metabolic syndromeMichael S Kostapanos, Matilda Florentin, Moses S Elisaf, et al.
Pageof 7